Robert Clarke, PhD
Dr. Clarke has served as chief executive officer of Pulmatrix and as a director of Pulmatrix since July 2012. Dr. Clarke joined Pulmatrix in April 2004 as its first Ph.D. scientist and served as the Chief Scientific Officer of Pulmatrix from May 2011 to September 2012, where he oversaw the research and development efforts focused on the iCALM and iSPERSE technologies. Prior to joining Pulmatrix, Mr. Clarke served as an Associate Director of Life Sciences at Alkermes, Inc. focusing on the development of inhaled therapeutic products based on the Advanced Inhalation Research (AIR) technology. Dr. Clarke holds a B.Sc. in Biomedical Engineering from Boston University and received his Ph.D. in Physiology from Johns Hopkins University. Dr. Clarke also completed post-doctoral training in Respiratory Biology at Brigham and Women’s Hospital and Harvard University. As a result of Dr. Clarke’s more than twenty (20) years of experience in the healthcare industry and his focus on pulmonary drug delivery and the role of inhaled particles in respiratory biology and medicine, including co-authorship of over 80 chapters, papers, and abstracts, Pulmatrix believes that Dr. Clarke is qualified to serve as a member of its board of directors.